GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » EV-to-Revenue

Center Laboratories (ROCO:4123) EV-to-Revenue : 19.36 (As of Jun. 03, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Center Laboratories's enterprise value is NT$31,619 Mil. Center Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was NT$1,633 Mil. Therefore, Center Laboratories's EV-to-Revenue for today is 19.36.

The historical rank and industry rank for Center Laboratories's EV-to-Revenue or its related term are showing as below:

ROCO:4123' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.31   Med: 19.81   Max: 73.22
Current: 19.36

During the past 13 years, the highest EV-to-Revenue of Center Laboratories was 73.22. The lowest was 1.31. And the median was 19.81.

ROCO:4123's EV-to-Revenue is ranked worse than
93.01% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs ROCO:4123: 19.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Center Laboratories's stock price is NT$39.50. Center Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$2.18. Therefore, Center Laboratories's PS Ratio for today is 18.11.


Center Laboratories EV-to-Revenue Historical Data

The historical data trend for Center Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories EV-to-Revenue Chart

Center Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.58 65.76 37.83 22.90 21.56

Center Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.07 27.07 23.52 21.56 18.04

Competitive Comparison of Center Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Center Laboratories's EV-to-Revenue falls into.


;
;

Center Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Center Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=31619.428/1633.318
=19.36

Center Laboratories's current Enterprise Value is NT$31,619 Mil.
Center Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,633 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Center Laboratories  (ROCO:4123) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Center Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=39.50/2.181
=18.11

Center Laboratories's share price for today is NT$39.50.
Center Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Center Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Center Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.

Center Laboratories Headlines

No Headlines